Biotech Values

[turtlepower]

TRGT-Envivo's results in schizo didn't seem to be that consistent. The higher dose was not significant for the PE but was significant for the some of the secondary endpoints and the lower dose was significant for only the PE. The 5619 doses are different so I think its difficult to say whether it'll have good results in schizo. The Envivo Alzheimers results seem more convincing so perhaps that should be the target indication that 5619 will clearly do well in. Also 5619 is behind Envivo's so unless there is some clear differentiating feature it will just be a me too drug.